Neuropeptides (substance P, CGRP, endogenous opioids, NGF) play central roles in pruritus (itch) pathophysiology, with neuropeptide-targeted therapies offering new treatment approaches for chronic itching conditions.
Key findingNeuropeptides (substance P, CGRP, endogenous opioids, NGF) play central roles in pruritus (itch) pathophysiology, with neuropeptide-targeted therapies
What the researchers found
Neuropeptides (substance P, CGRP, endogenous opioids, NGF) play central roles in pruritus (itch) pathophysiology, with neuropeptide-targeted therapies offering new treatment approaches for chronic itching conditions.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2011.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Pruritus: an overview of current concepts.
Veterinary dermatology, 22(2), 121-31
Citation
Metz, Martin; Grundmann, Sonja; Ständer, Sonja. (2011). Pruritus: an overview of current concepts.. Veterinary dermatology, 22(2), 121-31. https://doi.org/10.1111/j.1365-3164.2010.00945.x